Literature DB >> 22926298

Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia.

Mitchell T Harden1, Staci E Smith, Jennifer A Niehoff, Christopher R McCurdy, George T Taylor.   

Abstract

Salvinorin A (SalvA), the hallucinogenic derivative of the plant Salvia divinorum, is a selective κ-opioid receptor agonist that may also have antidepressant properties. Chronic mild stress (CMS) was applied to male and female Long-Evans rats to model anhedonia common in depression. The progressive loss in preference for a sucrose solution over plain water, a measure of anhedonia, and locomotor activity were monitored for 7 weeks. Because antidepressant medications often modify reproductive functions, endocrine glands and hormone-sensitive tissues were assessed at necropsy after the conclusion of the behavioral protocol. Three weeks of CMS exposure led to a decrease in sucrose preference. CMS was continued for 3 additional weeks and animals were randomly assigned to treatment with 1 mg SalvA/kg body weight or to a vehicle control group. The results indicate that SalvA reversed anhedonia whereas control animals continued to show a suppressed preference for the sucrose solution. In addition, no change in sucrose preference was observed in nonstressed rats that were exposed to the same dosage of SalvA. The results indicate that SalvA is an effective antidepressant agent when administered chronically to rats showing symptoms of depression similar to those observed in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926298     DOI: 10.1097/FBP.0b013e3283586189

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  12 in total

1.  The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.

Authors:  Aashish S Morani; Amy Ewald; Katherine M Prevatt-Smith; Thomas E Prisinzano; Bronwyn M Kivell
Journal:  Eur J Pharmacol       Date:  2013-11-04       Impact factor: 4.432

2.  The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.

Authors:  Amy W M Ewald; Peter J Bosch; Aimee Culverhouse; Rachel Saylor Crowley; Benjamin Neuenswander; Thomas E Prisinzano; Bronwyn M Kivell
Journal:  Psychopharmacology (Berl)       Date:  2017-05-23       Impact factor: 4.530

3.  Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.

Authors:  Veronica Serra; Liana Fattore; Maria Scherma; Roberto Collu; Maria Sabrina Spano; Walter Fratta; Paola Fadda
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

Review 4.  Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.

Authors:  Bronwyn M Kivell; Amy W M Ewald; Thomas E Prisinzano
Journal:  Adv Pharmacol       Date:  2014

5.  Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.

Authors:  B Simonson; A S Morani; A W M Ewald; L Walker; N Kumar; D Simpson; J H Miller; T E Prisinzano; B M Kivell
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Advances in novel molecular targets for antidepressants.

Authors:  Qingzhong Wang; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-16       Impact factor: 5.067

Review 7.  Post-stroke depression and the aging brain.

Authors:  Gabriel R Cojocaru; Aurel Popa-Wagner; Elena C Stanciulescu; Loredana Babadan; Ana-Maria Buga
Journal:  J Mol Psychiatry       Date:  2013-08-23

8.  Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans.

Authors:  Edward Orton; Renyu Liu
Journal:  Transl Perioper Pain Med       Date:  2014

Review 9.  Kappa Opioids, Salvinorin A and Major Depressive Disorder.

Authors:  George T Taylor; Francesca Manzella
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Authors:  Bronwyn M Kivell; Kelly F Paton; Nitin Kumar; Aashish S Morani; Aimee Culverhouse; Amy Shepherd; Susan A Welsh; Andrew Biggerstaff; Rachel S Crowley; Thomas E Prisinzano
Journal:  Molecules       Date:  2018-10-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.